These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Barriere SL; Guglielmo BJ Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812 [TBL] [Abstract][Full Text] [Related]
3. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin. Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845 [TBL] [Abstract][Full Text] [Related]
7. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody. Gorelick KJ; Chmel H Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775 [TBL] [Abstract][Full Text] [Related]
8. The current management of septic shock. Russel JA Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911 [TBL] [Abstract][Full Text] [Related]
9. Before-after study of a standardized hospital order set for the management of septic shock. Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733 [TBL] [Abstract][Full Text] [Related]
10. Sepsis and septic shock: selection of empiric antimicrobial therapy. Cunha BA Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948 [TBL] [Abstract][Full Text] [Related]
11. Severe pediatric sepsis. Nadel S Expert Rev Anti Infect Ther; 2012 Feb; 10(2):111-4. PubMed ID: 22339183 [No Abstract] [Full Text] [Related]
12. Nosocomial and community acquired bacteremia: variables associated with outcomes. Salomão R; Castelo Filho A; Pignatari AC; Wey SB Rev Paul Med; 1993; 111(6):456-61. PubMed ID: 8052793 [TBL] [Abstract][Full Text] [Related]
13. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department. Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336 [TBL] [Abstract][Full Text] [Related]
14. Antiendotoxin therapy in sepsis. Colletti RC; Dew RB; Goulart AE Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040 [TBL] [Abstract][Full Text] [Related]
15. Clinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock. Mohr NM; Fuller BM; Skrupky LP; Moy H; Alunday R; Micek ST; Fagley RE Ann Pharmacother; 2011 Oct; 45(10):1207-16. PubMed ID: 21934034 [TBL] [Abstract][Full Text] [Related]
16. Septic shock should be included in multivariable models analyzing the effect of empirical antibiotic therapy on mortality. Marcos M; Soriano A; Martínez JA; Mensa J Clin Infect Dis; 2007 Nov; 45(10):1401; author reply 1401-2. PubMed ID: 17968845 [No Abstract] [Full Text] [Related]
17. [Management of septic shock and acquired respiratory distress syndrome in pediatric cancer patients]. Bindl L; Nicolai T Klin Padiatr; 2005 Nov; 217 Suppl 1():S130-42. PubMed ID: 16288359 [TBL] [Abstract][Full Text] [Related]